Literature DB >> 26966869

ELECTRONIC MEDICAL RECORD DATABASE STUDY OF VITRECTOMY AND OBSERVATION FOR VITREOMACULAR TRACTION.

Timothy L Jackson1, Paul H J Donachie, Robert L Johnston.   

Abstract

PURPOSE: To audit the natural history of vitreomacular traction, and the risks and benefits of surgery.
METHODS: Database study of 1,254 patients (1,399 eyes) with vitreomacular traction from 16 UK vitreoretinal units.
RESULTS: The median age was 75 years, with 36.2% of patients diagnosed as diabetic. In 986 (70.5%) eyes managed conservatively, the median presenting logarithm of the minimum angle of resolution visual acuity of 0.30 (Snellen 20/40) was unchanged over follow-up. Of 413 eyes (29.5%) that required pars plana vitrectomy, the median preoperative visual acuity improved from 0.60 to 0.50 (20/80-20/63), 6 months to 12 months after surgery, with 33% gaining at least 0.3 units (approximately 2 Snellen lines). Vitrectomy was combined with internal limiting membrane peel in 43.8%, epiretinal membrane peel in 42.4%, gas/air tamponade in 46.2%, and cataract surgery in 27.9%. One or more intraoperative complications occurred in 12.6%; most commonly retinal breaks (8.0%), retinal trauma (1.9%), and retinal hemorrhage (1.0%). Postoperative retinal detachment occurred in 2.7% and macular hole in 2.2%. The 1, 2, and 3 year rates of postvitrectomy cataract surgery were 28.2%, 38.2%, and 42.7%, respectively.
CONCLUSION: Many eyes with vitreomacular traction have stable visual acuity. Those progressing to vitrectomy have relatively modest visual acuity gains, and complications are not infrequent.

Entities:  

Mesh:

Year:  2016        PMID: 26966869     DOI: 10.1097/IAE.0000000000001012

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

Review 1.  Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature.

Authors:  Benedicte Lescrauwaet; Koenraad Blot; Timothy L Jackson
Journal:  Patient Relat Outcome Meas       Date:  2019-03-27

2.  Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole.

Authors:  Craig Bennison; Stephanie Stephens; Benedicte Lescrauwaet; Ben Van Hout; Timothy L Jackson
Journal:  J Mark Access Health Policy       Date:  2016-06-23

3.  Effect of intravitreal C3F8 gas in patients with vitreomacular traction: A retrospective case series.

Authors:  Anna-Maria Haas; Christoph Mayer; Anton Haas; Werner Wackernagel
Journal:  Spektrum Augenheilkd       Date:  2017-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.